In the case of ER-positive breast carcinoma, higher expression of RelB is associated with decreased relapse-free survival (RFS) and overall survival (OS) rate, whereas in other tumours, such as lung carcinoma, enhanced expression of NIK and RelB is associated with enhanced metastasis and shorter OS. The gene discussed is RELB; the disease is lung carcinoma.